EGFR and non-small cell lung carcinoma: Since there was a significant interaction between NOTCH1 co‐mutation and treatment effect on OS in this IMPACT‐TR study, NOTCH1 co‐mutation may predict the efficacy of adjuvant gefitinib rather than simply being a prognostic factor in postoperative EGFR‐mutated NSCLC.